Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Zhou Q"" wg kryterium: Autor


Tytuł:
Coexistence of a novel intergenic (between CHST2 and SLC9A9)-ALK, TNIK-ALK double-fusion in resected lung adenocarcinoma.
Autorzy:
Liu Z; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang K; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wu Q; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhou Q; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: prof_qh_zhou@126.com.
Pokaż więcej
Źródło:
Asian journal of surgery [Asian J Surg] 2024 Mar; Vol. 47 (3), pp. 1505-1507. Date of Electronic Publication: 2023 Dec 09.
Typ publikacji:
Letter
MeSH Terms:
Adenocarcinoma of Lung*/genetics
Adenocarcinoma of Lung*/surgery
Adenocarcinoma*/genetics
Adenocarcinoma*/surgery
Adenocarcinoma*/pathology
Lung Neoplasms*/genetics
Lung Neoplasms*/surgery
Lung Neoplasms*/pathology
Humans ; Receptor Protein-Tyrosine Kinases ; Sodium-Hydrogen Exchangers
Opinia redakcyjna
Tytuł:
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Autorzy:
Maggie Liu SY; Department of Hematology, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China.
Huang J; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Deng JY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Chinese Thoracic Oncology Group (CTONG), Guangzhou 510055, China.
Yang MY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Li YS; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Ke EE; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Zheng MY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Wang Z; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Lin JX; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Gan B; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Zhang XC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Chen HJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Wang BC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China.
Li Y; Department of Hematology, The First Affiliated Hospital, Jinan University, Guangzhou 510632, China; Institute of Hematology, School of Medicine, Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou 510632, China. Electronic address: .
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Chinese Thoracic Oncology Group (CTONG), Guangzhou 510055, China. Electronic address: .
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou 510080, China; Chinese Thoracic Oncology Group (CTONG), Guangzhou 510055, China. Electronic address: .
Pokaż więcej
Źródło:
Science bulletin [Sci Bull (Beijing)] 2024 Feb 26; Vol. 69 (4), pp. 535-543. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Antibodies, Monoclonal, Humanized*
Humans ; B7-H1 Antigen/metabolism ; Prospective Studies
Czasopismo naukowe
Tytuł:
Optimal sequence of LT for symptomatic BM in EGFR-mutant NSCLC: a comparative study of first-line EGFR-TKIs with/without upfront LT.
Autorzy:
Niu L; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Wu H; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Jishou, 416000, China.
Gao R; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Chen L; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Wang J; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Duan H; Department of Oncology, Xiangxi Autonomous Prefecture People's Hospital, Jishou, 416000, China.
Long Y; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Xie Y; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China.
Zhou Q; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China. .
Zhou R; Department of Oncology, Xiangya Hospital, Central South University, 87 Xiangya Road, Kaifu District, Changsha, 410008, Hunan, China. .; Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, Changsha, 410008, China. .; National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China. .
Pokaż więcej
Źródło:
Journal of cancer research and clinical oncology [J Cancer Res Clin Oncol] 2024 Feb 19; Vol. 150 (2), pp. 94. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Prospective Studies ; Protein Kinase Inhibitors/therapeutic use ; ErbB Receptors/genetics ; Retrospective Studies ; Mutation
Czasopismo naukowe
Tytuł:
Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients.
Autorzy:
Tan X; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Department of Thoracic Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Xu T; Department of Thoracic Surgery, the Affiliated Hospital of Southwest Medical University, Luzhou, China.
Shen W; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Lung Cancer Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
Ai C; Department of Cardiothoracic Surgery, Bishan Hospital of Chongqing Medical University, Chongqing, China.
Zhang W; Lung Cancer Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.; Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, China.
Tang X; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Lung Cancer Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
Luo F; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
Zhou Q; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, China.; Lung Cancer Center, West China Tianfu Hospital, Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Thoracic cancer [Thorac Cancer] 2024 Feb; Vol. 15 (5), pp. 386-393. Date of Electronic Publication: 2023 Dec 26.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Adenoid Cystic*/genetics
Carcinoma, Adenoid Cystic*/therapy
Lung Neoplasms*/pathology
Male ; Female ; Humans ; Middle Aged ; Retrospective Studies ; In Situ Hybridization, Fluorescence ; China ; Prognosis
Czasopismo naukowe
Tytuł:
Comparison of the Efficacy and Safety of Perioperative Immunochemotherapeutic Strategies for Resectable Non-small Cell Lung Cancer: a Systematic Review and Network Meta-analysis.
Autorzy:
Mei T; Division of Thoracic Tumor Multidisciplinary Treatment, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, PR China; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China.
Zhou Q; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, PR China. Electronic address: prof_qh_zhou@126.com.
Gong Y; Division of Thoracic Tumor Multidisciplinary Treatment, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, PR China. Electronic address: .
Pokaż więcej
Źródło:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2024 Feb; Vol. 36 (2), pp. 107-118. Date of Electronic Publication: 2023 Dec 21.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/surgery
Lung Neoplasms*/drug therapy
Lung Neoplasms*/surgery
Humans ; Nivolumab/therapeutic use ; B7-H1 Antigen ; Network Meta-Analysis ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł:
Landscape of adenosine pathway and immune checkpoint dual blockade in NSCLC: progress in basic research and clinical application.
Autorzy:
Wang R; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu Z; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang T; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhang J; Department of Nutrition and Integrative Physiology, College of Health, University of Utah, Salt Lake City, UT, United States.
Liu J; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhou Q; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 29; Vol. 15, pp. 1320244. Date of Electronic Publication: 2024 Jan 29 (Print Publication: 2024).
Typ publikacji:
Journal Article; Review
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Humans ; Immune Checkpoint Inhibitors/therapeutic use ; Adenosine/metabolism ; Immunotherapy ; Tumor Microenvironment
Czasopismo naukowe
Tytuł:
[Clinical pathway in Chinese county for lung cancer diagnosis and treatment (2023 edition)].
Autorzy:
Wu YL; Guangdong Provincial People's Hospital, Guangdong Lung Cancer Institute, Guangzhou, 519041, China.
Zhou Q; Department of Pulmonary Medicine Ⅱ, Guangdong Provincial People's Hospital, Guangzhou 519041, China.
Pokaż więcej
Corporate Authors:
Chinese Thoracic
Źródło:
Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Jan 23; Vol. 46 (1), pp. 19-39.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Lung Neoplasms*/diagnosis
Lung Neoplasms*/drug therapy
Humans ; Critical Pathways ; Precision Medicine ; Diagnosis, Differential ; China
Czasopismo naukowe
Tytuł:
Pathological complete response to neoadjuvant therapy with serplulimab and chemotherapy in stage IIIB small cell lung cancer: a case report and literature review.
Autorzy:
Mei T; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang T; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Lei C; Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Jiang D; Department of Pathology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhou Q; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.; Lung Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2024 Jan 18; Vol. 14, pp. 1272450. Date of Electronic Publication: 2024 Jan 18 (Print Publication: 2023).
Typ publikacji:
Review; Case Reports
MeSH Terms:
Small Cell Lung Carcinoma*/drug therapy
Carcinoma, Non-Small-Cell Lung*/drug therapy
Lung Neoplasms*/drug therapy
Drug-Related Side Effects and Adverse Reactions*
Humans ; Neoadjuvant Therapy ; Antibodies, Monoclonal ; Immune Checkpoint Inhibitors ; Pathologic Complete Response
Recenzja
Tytuł:
Upregulation of E-cadherin by the combination of methionine restriction and HDAC2 intervention for inhibiting gastric carcinoma metastasis.
Autorzy:
Li Y; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Liu C
Xin L; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Liu C; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Cao J; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Yue Z; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Sheng J; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Yuan Y; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Zhou Q; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Liu Z; Department of General Surgery, the Second Affiliated Hospital of Nanchang University, Nanchang 330006, China, and Excellent Ophthalmology Class 221, School of Ophthalmology & Optometry, Nanchang University, Nanchang 330006, China.
Pokaż więcej
Źródło:
Acta biochimica et biophysica Sinica [Acta Biochim Biophys Sin (Shanghai)] 2023 Dec 21; Vol. 56 (1), pp. 62-70.
Typ publikacji:
Journal Article
MeSH Terms:
Stomach Neoplasms*/pathology
Lung Neoplasms*/genetics
Carcinoma*
Animals ; Up-Regulation ; Histones/metabolism ; Methionine/metabolism ; Cadherins/genetics ; Cadherins/metabolism ; Racemethionine/metabolism ; Cell Line, Tumor ; Cell Movement ; Neoplasm Invasiveness/genetics ; Gene Expression Regulation, Neoplastic
Czasopismo naukowe
Tytuł:
Deep learning of cell spatial organizations identifies clinically relevant insights in tissue images.
Autorzy:
Wang S; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA. .
Rong R; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhou Q; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Yang DM; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhang X; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Zhan X; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Bishop J; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Chi Z; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Wilhelm CJ; Department of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Zhang S; Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Pickering CR; Department of Surgery, Yale School of Medicine, New Haven, CT, USA.
Kris MG; Department of Thoracic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Minna J; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA.; Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.
Xie Y; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA.; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA.
Xiao G; Quantitative Biomedical Research Center, Peter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA. .; Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX, USA. .; Department of Bioinformatics, UT Southwestern Medical Center, Dallas, TX, USA. .
Pokaż więcej
Źródło:
Nature communications [Nat Commun] 2023 Dec 11; Vol. 14 (1), pp. 7872. Date of Electronic Publication: 2023 Dec 11.
Typ publikacji:
Journal Article
MeSH Terms:
Deep Learning*
Lung Neoplasms*/diagnostic imaging
Humans ; Cell Communication ; Cell Nucleus
Czasopismo naukowe
Tytuł:
Neoadjuvant nivolumab with or without platinum-doublet chemotherapy based on PD-L1 expression in resectable NSCLC (CTONG1804): a multicenter open-label phase II study.
Autorzy:
Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Dong S; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yang XN; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Liao RQ; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Jiang BY; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Wang Q; Department of Thoracic Surgery, Zhongshan Hospital, Fudan University, Shanghai, China.
Ben XS; Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Qiao GB; Department of Thoracic Surgery, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Lin JT; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yan LX; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Nie Q; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Wang BC; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Li HR; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China.; Berry Oncology Corporation, Fuzhou, China.
Liu K; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China.; Berry Oncology Corporation, Fuzhou, China.
Wu W; Fujian Key Laboratory of Advanced Technology for Cancer Screening and Early Diagnosis, Fuzhou, China.; Berry Oncology Corporation, Fuzhou, China.
Liu SM; Chinese Thoracic Oncology Group (CTONG), Guangzhou, China.; Department of Hematology, The First Affiliated Hospital, Jinan University, Guangzhou, China.
Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. .
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial Key Laboratory of Translational Medicine in Lung Cancer, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China. .
Pokaż więcej
Źródło:
Signal transduction and targeted therapy [Signal Transduct Target Ther] 2023 Dec 06; Vol. 8 (1), pp. 442. Date of Electronic Publication: 2023 Dec 06.
Typ publikacji:
Clinical Trial, Phase II; Multicenter Study; Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Lung Neoplasms*/pathology
Humans ; Nivolumab/therapeutic use ; Neoadjuvant Therapy/adverse effects ; Platinum/therapeutic use ; B7-H1 Antigen/genetics ; Prospective Studies
Czasopismo naukowe
Tytuł:
Tumor immune microenvironment-modulated nanostrategy for the treatment of lung cancer metastasis.
Autorzy:
Zhu L; Lung Cancer Center, Lung Cancer Institute, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, College of Polymer Science and Engineering, Sichuan University, Chengdu, Sichuan 610041, China.
Wu J; Out-patient Department, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Gao H; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, College of Polymer Science and Engineering, Sichuan University, Chengdu, Sichuan 610041, China.
Wang T; Lung Cancer Center, Lung Cancer Institute, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Xiao G; Lung Cancer Center, Lung Cancer Institute, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Hu C; Department of Critical Care Medicine, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Lin Q; Key Laboratory of Drug Targeting and Drug Delivery Systems, Ministry of Education, West China School of Pharmacy, College of Polymer Science and Engineering, Sichuan University, Chengdu, Sichuan 610041, China.
Zhou Q; Lung Cancer Center, Lung Cancer Institute, West China Hospital of Sichuan University, Chengdu, Sichuan 610041, China.
Pokaż więcej
Źródło:
Chinese medical journal [Chin Med J (Engl)] 2023 Dec 05; Vol. 136 (23), pp. 2787-2801. Date of Electronic Publication: 2023 Dec 05.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Lung Neoplasms*/therapy
Neoplasms*/drug therapy
Humans ; Tumor Microenvironment ; Immunotherapy/methods
Czasopismo naukowe
Tytuł:
Do elderly patients with stage I-IIA small cell lung cancer obtain survival benefits from surgery? A propensity score matching study.
Autorzy:
Wu Q; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Liu Z; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li P; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhou Q; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: .
Pokaż więcej
Źródło:
Asian journal of surgery [Asian J Surg] 2023 Dec; Vol. 46 (12), pp. 5540-5542. Date of Electronic Publication: 2023 Sep 13.
Typ publikacji:
Letter
MeSH Terms:
Small Cell Lung Carcinoma*/surgery
Lung Neoplasms*/pathology
Carcinoma, Non-Small-Cell Lung*
Humans ; Aged ; Propensity Score ; Pneumonectomy ; Neoplasm Staging ; Retrospective Studies
Opinia redakcyjna
Tytuł:
A novel intergenic (between REG3A and CTNNA2-AS1)-ALK fusion responds to alectinib in lung adenocarcinoma.
Autorzy:
Liu Z; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wu Q; Department of Radiation Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li W; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Li P; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Huang L; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Wang T; Department of Medical Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Zhou Q; Lung Cancer Center & Institute, West China Hospital, Sichuan University, Chengdu, Sichuan, China; Department of Thoracic Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China. Electronic address: .
Pokaż więcej
Źródło:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Dec; Vol. 186, pp. 107386. Date of Electronic Publication: 2023 Oct 05.
Typ publikacji:
Case Reports; Research Support, Non-U.S. Gov't
MeSH Terms:
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Adenocarcinoma of Lung*/drug therapy
Adenocarcinoma of Lung*/genetics
Male ; Humans ; Middle Aged ; Anaplastic Lymphoma Kinase/genetics ; Protein Kinase Inhibitors/therapeutic use ; Carbazoles/therapeutic use
Raport
Tytuł:
Kaempferol promotes non-small cell lung cancer cell autophagy via restricting Met pathway.
Autorzy:
Wang R; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Deng Z; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Zhu Z; Department of Pharmacy, Guangdong Provincial Hospital of Chinese Medicine, The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Wang J; State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Yang X; Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Xu M; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Wang X; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Tang Q; Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Zhou Q; Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Wan X; The Second Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China.
Wu W; Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China. Electronic address: .
Wang S; Clinical and Basic Research Team of TCM Prevention and Treatment of NSCLC, Department of Oncology, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangdong Provincial Hospital of Chinese Medicine, Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, State Key Laboratory of Dampness Syndrome of Chinese Medicine, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510120, China. Electronic address: .
Pokaż więcej
Źródło:
Phytomedicine : international journal of phytotherapy and phytopharmacology [Phytomedicine] 2023 Dec; Vol. 121, pp. 155090. Date of Electronic Publication: 2023 Sep 16.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/metabolism
Lung Neoplasms*/metabolism
Humans ; Animals ; Mice ; Mice, Nude ; Proto-Oncogene Proteins c-akt/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; Kaempferols/pharmacology ; Mice, Inbred BALB C ; TOR Serine-Threonine Kinases/metabolism ; Autophagy ; RNA, Messenger ; Cell Proliferation ; Cell Line, Tumor
Czasopismo naukowe
Tytuł:
Deep Learning With an Attention Mechanism for Differentiating the Origin of Brain Metastasis Using MR images.
Autorzy:
Jiao T; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.; Shandong First Medical University, Jinan, China.
Li F; Department of Radiology, Shandong Provincial Hospital affiliated to Shandong First Medical University, Jinan, China.
Cui Y; Department of Radiology, Qilu Hospital of Shandong University, Jinan, China.
Wang X; Department of Radiology, Jining No. 1 People's Hospital, Jining, China.
Li B; Department of Radiation Oncology, Shandong Cancer Hospital & Institute, Jinan, China.
Shi F; Shanghai United Imaging Intelligence, Shanghai, China.
Xia Y; Shanghai United Imaging Intelligence, Shanghai, China.
Zhou Q; Shanghai United Imaging Intelligence, Shanghai, China.
Zeng Q; Department of Radiology, The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital, Jinan, China.
Pokaż więcej
Źródło:
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2023 Nov; Vol. 58 (5), pp. 1624-1635. Date of Electronic Publication: 2023 Mar 25.
Typ publikacji:
Journal Article
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Deep Learning*
Lung Neoplasms*/diagnostic imaging
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/pathology
Breast Neoplasms*
Humans ; Female ; Middle Aged ; Diffusion Magnetic Resonance Imaging/methods ; Retrospective Studies ; Magnetic Resonance Imaging/methods
Czasopismo naukowe
Tytuł:
Mitochondria-related lncRNAs: predicting prognosis, tumor microenvironment and treatment response in lung adenocarcinoma.
Autorzy:
Zhou Q; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Xiong J; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Gao Y; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Yi R; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Xu Y; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Chen Q; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Wang L; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China.
Chen Y; Department of Respiratory and Critical Care Medicine, Zhuzhou Central Hospital, Zhuzhou, 412000, Hunan, China. .
Pokaż więcej
Źródło:
Functional & integrative genomics [Funct Integr Genomics] 2023 Oct 21; Vol. 23 (4), pp. 323. Date of Electronic Publication: 2023 Oct 21.
Typ publikacji:
Journal Article
MeSH Terms:
RNA, Long Noncoding*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Adenocarcinoma*
Humans ; Tumor Microenvironment/genetics ; Mitochondria/genetics ; Lung
Czasopismo naukowe
Tytuł:
Efficacy and safety of pralsetinib in patients with advanced RET fusion-positive non-small cell lung cancer.
Autorzy:
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Zhao J; Beijing Cancer Hospital, Beijing, China.
Chang J; Fudan University Shanghai Cancer Center, Shanghai, China.
Wang H; Fudan University Shanghai Cancer Center, Shanghai, China.
Fan Y; Zhejiang Cancer Hospital, Hangzhou, China.
Wang K; West China Hospital Sichuan University, Chengdu, China.
Wu G; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Nian W; Chongqing Cancer Hospital, Chongqing, China.
Sun Y; Jinan Central Hospital, Jinan, China.
Sun M; Jinan Central Hospital, Jinan, China.
Wang X; First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Shi H; First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Zheng X; Tianjin Medical University Cancer Institute & Hospital, Tianjin, China.
Yao S; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China.
Qin M; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China.
Shen Z; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China.
Yang J; CStone Pharmaceuticals (Su Zhou) Co., Ltd., Suzhou, China.
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
Pokaż więcej
Źródło:
Cancer [Cancer] 2023 Oct 15; Vol. 129 (20), pp. 3239-3251. Date of Electronic Publication: 2023 Jun 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/drug therapy
Carcinoma, Non-Small-Cell Lung*/genetics
Lung Neoplasms*/drug therapy
Lung Neoplasms*/genetics
Adult ; Humans ; Pyridines/therapeutic use ; Pyrazoles/therapeutic use ; Protein Kinase Inhibitors/adverse effects ; Proto-Oncogene Proteins c-ret
Czasopismo naukowe
Tytuł:
Dynamic circulating tumor DNA during chemoradiotherapy predicts clinical outcomes for locally advanced non-small cell lung cancer patients.
Autorzy:
Pan Y; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Zhang JT; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Gao X; Geneplus-Beijing Institute, Beijing, China.
Chen ZY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yan B; Geneplus-Beijing Institute, Beijing, China.
Tan PX; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yang XR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Gao W; Geneplus-Beijing Institute, Beijing, China.
Gong Y; Geneplus-Beijing Institute, Beijing, China.
Tian Z; Geneplus-Beijing Institute, Beijing, China.
Liu SM; Department of Hematology, First Affiliated Hospital, Institute of Hematology, School of Medicine; Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University, Guangzhou, Guangdong, China; Chinese Thoracic Oncology Group (CTONG), Guangzhou, Guangdong, China.
Lin H; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Sun H; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Huang J; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Liu SY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yan HH; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Dong S; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Xu CR; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Chen HJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Wang Z; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Li P; Geneplus-Beijing Institute, Beijing, China.
Guan Y; Geneplus-Beijing Institute, Beijing, China.
Wang BC; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yang JJ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Tu HY; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Yang XN; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Zhong WZ; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China.
Xia X; Geneplus-Beijing Institute, Beijing, China.
Yi X; Geneplus-Beijing Institute, Beijing, China. Electronic address: .
Zhou Q; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China. Electronic address: .
Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, China; Chinese Thoracic Oncology Group (CTONG), Guangzhou, Guangdong, China. Electronic address: .
Pokaż więcej
Źródło:
Cancer cell [Cancer Cell] 2023 Oct 09; Vol. 41 (10), pp. 1763-1773.e4.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/genetics
Carcinoma, Non-Small-Cell Lung*/therapy
Circulating Tumor DNA*/genetics
Lung Neoplasms*/genetics
Lung Neoplasms*/therapy
Humans ; Prospective Studies ; Chemoradiotherapy ; Biomarkers, Tumor/genetics
Czasopismo naukowe
Tytuł:
Whole-tumor histogram analysis of multi-parametric MRI for differentiating brain metastases histological subtypes in lung cancers: relationship with the Ki-67 proliferation index.
Autorzy:
Zhang B; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Zhou F; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Zhou Q; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Xue C; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Ke X; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Zhang P; Department of Pathology, Lanzhou University Second Hospital, Lanzhou, Gansu, China.
Han T; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Deng L; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Jing M; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China.
Zhou J; Department of Radiology, Lanzhou University Second Hospital, Cuiyingmen No. 82, Chengguan District, Lanzhou, Gansu, 730030, People's Republic of China. ery_.; Second Clinical School, Lanzhou University, Lanzhou, Gansu, China. ery_.; Key Laboratory of Medical Imaging of Gansu Province, Lanzhou University Second Hospital, Lanzhou, Gansu, China. ery_.; Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou, Gansu, China. ery_.
Pokaż więcej
Źródło:
Neurosurgical review [Neurosurg Rev] 2023 Sep 02; Vol. 46 (1), pp. 218. Date of Electronic Publication: 2023 Sep 02.
Typ publikacji:
Journal Article
MeSH Terms:
Lung Neoplasms*/diagnostic imaging
Carcinoma, Non-Small-Cell Lung*/diagnostic imaging
Brain Neoplasms*/diagnostic imaging
Male ; Humans ; Female ; Ki-67 Antigen ; Retrospective Studies ; Cell Proliferation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies